Veru Inc. (VERU)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Mitchell S. Steiner F.A.C.S., M.D. | Chairman, President & CEO | 1.46M | -- | 1961 |
| Dr. Harry D. Fisch F.A.C.S., M.D. | Vice Chairman & Chief Corporate Officer | 708.45k | -- | 1959 |
| Dr. K. Gary Barnette Ph.D. | Chief Scientific Officer | 862.55k | -- | 1968 |
| Ms. Michele Greco CPA | CFO & Chief Administrative Officer | 493.7k | -- | 1959 |
| Mr. Samuel Fisch | Executive Director of Investor Relations & Corporate Communications | -- | -- | -- |
| Mr. Michael J. Purvis J.D. | Executive VP, General Counsel & Corporate Strategy and Secretary | -- | -- | -- |
| Mr. Kevin J. Gilbert CPA, J.D. | Executive Vice President of Corporate Development | -- | -- | -- |
| Mr. Martin Tayler | Executive Vice President of FC2 Global Operations | 180.51k | -- | 1969 |
| Mr. Philip R. Greenberg J.D. | Executive VP & Deputy General Counsel | -- | -- | -- |
| Dr. Domingo Rodriguez M.D. | Executive Vice President of Global Clinical Operations | -- | -- | 1962 |
Veru Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 210
Description
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Corporate Governance
Upcoming Events
August 6, 2025 at 12:30 PM UTC - August 11, 2025 at 12:30 PM UTC
Veru Inc. Earnings Date
Recent Events
December 12, 2024 at 12:00 AM UTC
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing